A change observed during a dietary manipulation is not necessarily caused by that diet. An eight-baboon experiment tested whether periodic high-sugar candy consumption would blunt d-amphetamine’s suppression of food intake. The expected amphetamine tolerance did not emerge. Follow-up after candy access stopped was central to understanding why.
The study was a controlled nonhuman-primate feeding experiment, not evidence that sugar treats stimulant effects or that changing a person’s diet predictably alters an amphetamine dose response.
How was food access arranged?
Foltin studied eight experimentally naive adult male baboons, initially weighing 17.5–23.1 kg. Animals earned food through operant-response schedules, with brief morning opportunities and longer pellet-meal sessions. They were not simply offered unrestricted candy alongside an otherwise unchanged free-feeding diet.
After baseline drug testing, candy replaced morning pellets on Mondays, Wednesdays and Fridays. Availability increased over successive weeks until up to 200 pieces could be earned on those mornings. Candy supplied approximately 75% of its energy as sugar; the standard pellets supplied about 19%.
Baboons reduced other pellet intake when candy was available and also ate less on non-candy days. The authors reported near compensation across the week and no accelerated rate of weight gain during candy access. High morning candy intake therefore was not equivalent to an equally large sustained increase in total weekly energy.
When were the drugs tested?
D-amphetamine hydrochloride at 0.06–0.5 mg/kg and dexfenfluramine hydrochloride at 0.12–1.0 mg/kg were administered intramuscularly in a thigh muscle at 8:50 a.m. on Tuesdays and Thursdays. Doses were expressed as salt weights.
Those were days without candy. The question was whether the ongoing history of periodic candy access changed responses to drugs while animals earned pellets, rather than whether simultaneously eating candy immediately reversed a drug effect.
Dose–response functions were obtained before candy access, during the candy-access period, and after six months without candy. Dose order was varied within and across animals, with placebo days included. The overall before–during–after sequence was not randomized.
Which outcomes were measured?
The principal measures were pellets earned during brief morning sessions, pellets earned during afternoon meal sessions, and latency to the first afternoon pellet. Latency included a required food-acquisition period; its minimum was approximately 30 minutes under this schedule.
Because baseline pellet intake changed with candy availability, drug results were analyzed as changes from baseline. Those baseline shifts remain important even after adjustment: the same numerical reduction can have a different meaning when the comparison intake is already lower.
No plasma amphetamine, brain dopamine or serotonin concentration was measured in these animals. Proposed neurotransmitter explanations were hypotheses, not direct chemical findings from this experiment.
Did candy access produce the predicted amphetamine tolerance?
The authors concluded that it did not. Their abstract and discussion described increased sensitivity to some amphetamine feeding effects as the study progressed, rather than the predicted blunting. Crucially, the altered amphetamine response persisted after candy access ended.
That persistence weakened an explanation tied specifically to concurrent candy availability. Repeated intermittent amphetamine testing, elapsed time, experience with the task and other sequential changes remained possible contributors.
The paper also contains an interpretive caution: its detailed results prose describes some afternoon amphetamine changes as “smaller,” while the abstract and discussion describe increased sensitivity. The present commentary does not assign a precise endpoint-specific dietary effect from those inconsistent descriptions. The authors’ broader conclusion—that the predicted candy-related amphetamine tolerance was not established—is the defensible emphasis.
Why was the comparison drug useful?
Dexfenfluramine showed a different pattern. Its dose–response function shifted toward reduced sensitivity during candy access and returned toward the earlier pattern after candy stopped. For example, 0.5 mg/kg reduced brief-session pellet intake by about half before and after candy access but had no reported effect on that measure during candy availability.
The contrast demonstrated that the experiment could detect a change associated with the dietary phase. It did not establish that amphetamine and dexfenfluramine act through completely separate systems or that one can use the latter’s result to infer the former’s mechanism.
The author proposed a relationship between repeated palatable-food intake and serotonin-mediated satiation. That interpretation required further testing, including designs able to separate diet from other phase-related experiences.
What limits a causal conclusion?
All eight animals experienced the phases in the same broad temporal order, and drug-testing order differed between phases. There was no concurrent group maintained on the original diet throughout the entire sequence. Candy availability, task history, repeated drug testing and aging were therefore not fully separated.
The sample consisted only of male baboons under a specific food-earning schedule. The type and amount of high-sugar food were limited by the design. The study did not measure human appetite, clinical weight loss, stimulant safety or functional impairment.
Its strongest methodological contribution is the follow-up comparison: a response that persists after a manipulation ends needs a different interpretation from one that returns toward baseline. Neither pattern alone proves its molecular cause, but preserving that distinction prevents an unsupported claim that sugar neutralizes amphetamine.
Scientific source
Foltin RW. Consumption of palatable food decreases the anorectic effects of serotonergic, but not dopaminergic drugs in baboons. Physiology & Behavior. 2011;103(5):493–500. doi:10.1016/j.physbeh.2011.04.004. Full-text author manuscript. Historical original nonhuman-primate experiment.
Leave a Reply